Radiosynthesis of an 18 F-fluoroglycosylated aminoferrocene for in-vivo imaging of reactive oxygen species activity by PET

The imaging of reactive oxygen species (ROS) at the molecular level with high sensitivity and specificity by positron emission tomography (PET) could be of enormous interest to increase our knowledge about ROS activity and signalling, especially in tumours. The aim of this research was to optimise t...

Full description

Saved in:
Bibliographic Details
Published inJournal of labelled compounds & radiopharmaceuticals Vol. 61; no. 14; pp. 1081 - 1088
Main Authors Toms, Johannes, Reshetnikov, Viktor, Maschauer, Simone, Mokhir, Andriy, Prante, Olaf
Format Journal Article
LanguageEnglish
Published England 01.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The imaging of reactive oxygen species (ROS) at the molecular level with high sensitivity and specificity by positron emission tomography (PET) could be of enormous interest to increase our knowledge about ROS activity and signalling, especially in tumours. The aim of this research was to optimise the click chemistry-based radiosynthesis of an F-labelled aminoferrocene glycoconjugate that was derived from an N-alkylaminoferrocene lead structure known to have anticancer activity in vitro. Applying the solvent system phosphate buffer/THF (12/5), Cu(OAc) and sodium ascorbate as reducing agent at 60°C, the alkyne 1 reacted with the F-labelled glycosyl azide [ F]2 in the presence of carrier 3 (47μM) to obtain carrier-added [ F]4 in a radiochemical yield of 85%. Interestingly, the addition of carrier was essential for sufficient radiochemical yield, because it suppressed the oxidation of no-carrier-added (n.c.a.) [ F]4. Future work will include the formulation of c.a. [ F]4 for studying its biodistribution in tumour-bearing mice.
AbstractList The imaging of reactive oxygen species (ROS) at the molecular level with high sensitivity and specificity by positron emission tomography (PET) could be of enormous interest to increase our knowledge about ROS activity and signalling, especially in tumours. The aim of this research was to optimise the click chemistry-based radiosynthesis of an F-labelled aminoferrocene glycoconjugate that was derived from an N-alkylaminoferrocene lead structure known to have anticancer activity in vitro. Applying the solvent system phosphate buffer/THF (12/5), Cu(OAc) and sodium ascorbate as reducing agent at 60°C, the alkyne 1 reacted with the F-labelled glycosyl azide [ F]2 in the presence of carrier 3 (47μM) to obtain carrier-added [ F]4 in a radiochemical yield of 85%. Interestingly, the addition of carrier was essential for sufficient radiochemical yield, because it suppressed the oxidation of no-carrier-added (n.c.a.) [ F]4. Future work will include the formulation of c.a. [ F]4 for studying its biodistribution in tumour-bearing mice.
The imaging of reactive oxygen species (ROS) at the molecular level with high sensitivity and specificity by positron emission tomography (PET) could be of enormous interest to increase our knowledge about ROS activity and signalling, especially in tumours. The aim of this research was to optimise the click chemistry‐based radiosynthesis of an 18 F‐labelled aminoferrocene glycoconjugate that was derived from an N‐alkylaminoferrocene lead structure known to have anticancer activity in vitro. Applying the solvent system phosphate buffer/THF (12/5), Cu(OAc) 2 and sodium ascorbate as reducing agent at 60°C, the alkyne 1 reacted with the 18 F‐labelled glycosyl azide [ 18 F] 2 in the presence of carrier 3 (47μM) to obtain carrier‐added [ 18 F] 4 in a radiochemical yield of 85%. Interestingly, the addition of carrier was essential for sufficient radiochemical yield, because it suppressed the oxidation of no‐carrier‐added (n.c.a.) [ 18 F] 4 . Future work will include the formulation of c.a. [ 18 F] 4 for studying its biodistribution in tumour‐bearing mice.
Author Toms, Johannes
Prante, Olaf
Maschauer, Simone
Mokhir, Andriy
Reshetnikov, Viktor
Author_xml – sequence: 1
  givenname: Johannes
  surname: Toms
  fullname: Toms, Johannes
  organization: Department of Nuclear Medicine, Molecular Imaging and Radiochemistry, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
– sequence: 2
  givenname: Viktor
  surname: Reshetnikov
  fullname: Reshetnikov, Viktor
  organization: Department of Chemistry and Pharmacy, Organic Chemistry Chair II, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
– sequence: 3
  givenname: Simone
  surname: Maschauer
  fullname: Maschauer, Simone
  organization: Department of Nuclear Medicine, Molecular Imaging and Radiochemistry, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
– sequence: 4
  givenname: Andriy
  orcidid: 0000-0002-9079-5569
  surname: Mokhir
  fullname: Mokhir, Andriy
  organization: Department of Chemistry and Pharmacy, Organic Chemistry Chair II, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
– sequence: 5
  givenname: Olaf
  orcidid: 0000-0003-0247-3656
  surname: Prante
  fullname: Prante, Olaf
  organization: Department of Nuclear Medicine, Molecular Imaging and Radiochemistry, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30303563$$D View this record in MEDLINE/PubMed
BookMark eNo9kM1OwzAQhC1URH_gwAsgH-GQYsdOnBxR1QJSJRAq58h1NsFVYhc7rQhPj0sL2sNqd0ejnW-MBsYaQOiakiklJL7fNMpNWZqJMzSiJM8jyjgfoBFhaRzxjLAhGnu_ISTcOL9AQ0ZCJSkboe83WWrre9N9gNce2wpLg2mGF1HV7KyzddOrcG9kByWWrTa2AuesAgO4sg5rE-313mLdylqb-mDgQKpO7wHbr74Gg_0WlAaPf7e66_G6x6_z1SU6r2Tj4erUJ-h9MV_NnqLly-Pz7GEZKRq-jGiSMZHTJEm4yMsspYrxCkqREsljkZUsZApTznMiZFxyCUzmjCsGoqJExGyCbo--W2c_d-C7otVeQdNIA3bni5hSkdE8TnmQ3h2lylnvHVTF1oVgri8oKQ6oiwPq4oA6aG9Otrt1C-W_8o8t-wFR5nuU
CitedBy_id crossref_primary_10_1021_acs_bioconjchem_9b00019
crossref_primary_10_1021_acs_bioconjchem_3c00286
crossref_primary_10_1002_INMD_20230002
crossref_primary_10_1016_j_jinorgbio_2022_111859
crossref_primary_10_1039_D2DT03161B
crossref_primary_10_3390_ph14111175
crossref_primary_10_3389_fvets_2022_850771
crossref_primary_10_3390_cancers14010208
crossref_primary_10_1002_ejic_202100829
crossref_primary_10_1021_acs_bioconjchem_2c00050
crossref_primary_10_1039_D0DT02135K
Cites_doi 10.1021/mp4004817
10.1196/annals.1427.007
10.1038/jcbfm.1988.28
10.1021/ja509198w
10.1021/om00136a033
10.1002/chem.201604473
10.1021/acs.bioconjchem.6b00472
10.2967/jnumed.112.115436
10.1021/jm2014937
10.1016/j.nucmedbio.2017.05.011
10.1002/anie.200904137
10.1016/j.nucmedbio.2017.09.004
10.1016/j.carres.2009.02.001
10.1002/anie.201706585
10.1021/acs.jmedchem.6b00675
10.1602/neurorx.2.1.44
10.1089/ars.2015.6415
10.1039/C3OB42379D
10.1016/S0955-0674(03)00002-4
ContentType Journal Article
Copyright 2018 John Wiley & Sons, Ltd.
Copyright_xml – notice: 2018 John Wiley & Sons, Ltd.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1002/jlcr.3687
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1099-1344
EndPage 1088
ExternalDocumentID 10_1002_jlcr_3687
30303563
Genre Journal Article
GrantInformation_xml – fundername: Emerging Fields Initiative (EFI) of the Friedrich-Alexander University Erlangen-Nürnberg (FAU)
  grantid: 3_Nat_01
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIJN
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AI.
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
GWYGA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LITHE
LOXES
LP6
LP7
LUTES
LYRES
M6Q
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
NPM
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
SAMSI
SUPJJ
TUS
UB1
V2E
VH1
W8V
W99
WBFHL
WBKPD
WH7
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WUP
WWP
WXSBR
WYISQ
XG1
XV2
YCJ
ZZTAW
~IA
~WT
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c1303-1583791555479d861c34fed760a4278d3994d7694907a2d4ae3a934c3e7f10723
ISSN 0362-4803
IngestDate Sat Aug 17 00:34:11 EDT 2024
Fri Aug 23 02:41:17 EDT 2024
Sat Sep 28 08:40:18 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 14
Keywords click chemistry
positron emission tomography
F-18
reactive oxygen species
Language English
License 2018 John Wiley & Sons, Ltd.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1303-1583791555479d861c34fed760a4278d3994d7694907a2d4ae3a934c3e7f10723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0247-3656
0000-0002-9079-5569
PMID 30303563
PQID 2117819264
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2117819264
crossref_primary_10_1002_jlcr_3687
pubmed_primary_30303563
PublicationCentury 2000
PublicationDate 2018-Dec
2018-12-00
20181201
PublicationDateYYYYMMDD 2018-12-01
PublicationDate_xml – month: 12
  year: 2018
  text: 2018-Dec
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of labelled compounds & radiopharmaceuticals
PublicationTitleAlternate J Labelled Comp Radiopharm
PublicationYear 2018
References e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
Daum S (e_1_2_7_19_1) 2018
e_1_2_7_17_1
Maschauer S (e_1_2_7_18_1) 2014
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_25_1
e_1_2_7_24_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_22_1
e_1_2_7_10_1
e_1_2_7_21_1
e_1_2_7_20_1
Sasaki T (e_1_2_7_7_1) 1996; 37
Reshetnikov MSV (e_1_2_7_13_1) 2018
Hall DG (e_1_2_7_23_1) 2006
References_xml – ident: e_1_2_7_20_1
  doi: 10.1021/mp4004817
– ident: e_1_2_7_5_1
  doi: 10.1196/annals.1427.007
– ident: e_1_2_7_6_1
  doi: 10.1038/jcbfm.1988.28
– ident: e_1_2_7_10_1
  doi: 10.1021/ja509198w
– ident: e_1_2_7_24_1
  doi: 10.1021/om00136a033
– ident: e_1_2_7_11_1
  doi: 10.1002/chem.201604473
– ident: e_1_2_7_16_1
  doi: 10.1021/acs.bioconjchem.6b00472
– year: 2018
  ident: e_1_2_7_19_1
  article-title: Identification of active species derived from anticancer N‐alkylaminoferrocene‐based prodrugs and their radiolabeling with 18F
  publication-title: Bioconjug Chem
  contributor:
    fullname: Daum S
– ident: e_1_2_7_4_1
  doi: 10.2967/jnumed.112.115436
– ident: e_1_2_7_25_1
  doi: 10.1021/jm2014937
– ident: e_1_2_7_9_1
  doi: 10.1016/j.nucmedbio.2017.05.011
– volume-title: Boronic acids: preparation, applications in organic synthesis and medicine
  year: 2006
  ident: e_1_2_7_23_1
  contributor:
    fullname: Hall DG
– volume: 37
  start-page: 1698
  issue: 10
  year: 1996
  ident: e_1_2_7_7_1
  article-title: Assessment of antioxidative ability in brain: technetium‐99m‐meso‐HMPAO as an imaging agent for glutathione localization
  publication-title: J Nucl Med
  contributor:
    fullname: Sasaki T
– start-page: 16
  year: 2014
  ident: e_1_2_7_18_1
  article-title: Sweetening pharmaceutical radiochemistry by 18F‐fluoroglycosylation: a short review
  publication-title: Biomed Res Int
  contributor:
    fullname: Maschauer S
– ident: e_1_2_7_15_1
  doi: 10.1002/anie.200904137
– ident: e_1_2_7_21_1
  doi: 10.1016/j.nucmedbio.2017.09.004
– ident: e_1_2_7_22_1
  doi: 10.1016/j.carres.2009.02.001
– ident: e_1_2_7_12_1
  doi: 10.1002/anie.201706585
– volume-title: unpublished results
  year: 2018
  ident: e_1_2_7_13_1
  contributor:
    fullname: Reshetnikov MSV
– ident: e_1_2_7_17_1
  doi: 10.1021/acs.jmedchem.6b00675
– ident: e_1_2_7_14_1
  doi: 10.1602/neurorx.2.1.44
– ident: e_1_2_7_3_1
  doi: 10.1089/ars.2015.6415
– ident: e_1_2_7_8_1
  doi: 10.1039/C3OB42379D
– ident: e_1_2_7_2_1
  doi: 10.1016/S0955-0674(03)00002-4
SSID ssj0009944
Score 2.1988146
Snippet The imaging of reactive oxygen species (ROS) at the molecular level with high sensitivity and specificity by positron emission tomography (PET) could be of...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 1081
Title Radiosynthesis of an 18 F-fluoroglycosylated aminoferrocene for in-vivo imaging of reactive oxygen species activity by PET
URI https://www.ncbi.nlm.nih.gov/pubmed/30303563
https://search.proquest.com/docview/2117819264
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9owELXo9tBeqn6XfsmtekPZxrGTOMdqC1pVu9tqFSRukZM4JQUSFAgq-0P6ezuOHQgSK217iUgQBmaePM_2zBuEPhGaxRnlruULblvAiB1LSDu1vDRLIDzHIm56HV5eeedj9m3iTnq9P52spXodnyY3R-tK_ser8Az8qqpk_8Gzu0HhAbwG_8IVPAzXO_n4WqR5udoWQOKMrojqt8cHIyub12VV_pxvE3h_LhStFIu8KDNZqYhVaKnvvLA2-aYc5AvTqygbAIdsZsBB-XsL3ztQlZiwmG40N5o2E0BXfwzDWzgtQEodBDSVckvVsGnVQKtSv3M57e6e76h8WC7MUcRUwJy_T72Xq6lcF_ms3DS5uPlM6yKb_XNYlIvaNA0DuO2TAy7L2TSv2lzNfNvd1iC8kyIi9VSstEMJ1eqQ7VythdtbTLLOzEtsTjpRHG750QihFWd_zZPqlHom1h-ocF99j0bji4soHE7Ce-i-4weuShX9er2XJQsCxlqVKtv5vBvskNvcsmBpiEv4GD0y3sFfNHyeoJ4snqIHZ22jv2fo5hBGuMywKDDh-BiM8CGMMMAIGxhhAyM1QAsjrGGEDYxwCyMcbzHA6Dkaj4bh2bllWnJYiSI7FnE59VVLAZf5Qco9klCWydT3bKF6tqRAdxncBSywfeGkTEgqAsoSKv2M2L5DX6CTAjDxCmGaEU_GcWbbCWdpwLkXqCJnR0gIC7ET99HH1pjRUiuvRFpj24mUxSNl8T760Jo5Aqupwy5RyLJeRQ4hvhL781gfvdT23w0D_8Smrkdf3-HTb9DDPTzfopN1Vct3wEPX8fsGFH8BA4uTBA
link.rule.ids 315,786,790,27955,27956
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Radiosynthesis+of+an+18+F-fluoroglycosylated+aminoferrocene+for+in-vivo+imaging+of+reactive+oxygen+species+activity+by+PET&rft.jtitle=Journal+of+labelled+compounds+%26+radiopharmaceuticals&rft.au=Toms%2C+Johannes&rft.au=Reshetnikov%2C+Viktor&rft.au=Maschauer%2C+Simone&rft.au=Mokhir%2C+Andriy&rft.date=2018-12-01&rft.eissn=1099-1344&rft.volume=61&rft.issue=14&rft.spage=1081&rft.epage=1088&rft_id=info:doi/10.1002%2Fjlcr.3687&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0362-4803&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0362-4803&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0362-4803&client=summon